Article Text

Download PDFPDF
Determinants of quality of life in advanced kidney disease: time to screen?
  1. Osasuyi Iyasere,
  2. Edwina A Brown
  1. Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK
  1. Correspondence to Dr Osasuyi Iyasere, Imperial College Renal and Transplant Centre, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK; o.iyasere13{at}


The incidence of older patients with end stage renal disease is on the increase. This group of patients have multiple comorbidities and a high symptom burden. Dialysis can be life sustaining for such patients. But it is often at the expense of quality of life, which starts to decline early in the pathway of chronic kidney disease. Quality of life is also important to patients and is a major determinant in decisions regarding renal replacement. As a result, validated patient-reported outcome measures are increasingly used to assess quality of life in renal patients. Cognitive impairment, depression, malnutrition and function decline are non-renal determinants of quality of life and mortality. They are under-recognised in the renal population but are potentially treatable, if not preventable. This review article discusses aetio-pathogenesis, prevalence and impact of these four outcomes, advocating regular screening for early identification and management.

  • Quality of life
  • Cognitive impairment
  • Depression
  • Physical Function
  • advanced kidney disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.